Category

Funding stage

More

• Overfunding - Over 100%
Vessi Medical

Vessi Medical

VessiMedical has developed a device that eliminates bladder cancer cells using freezing technology (Cryotherapy). The treatment allows the elimination of cancerous cells while improves the quality of life and reduces the chance of tumor recurrence.

17

Units lefts

19

Days to go

$10,000

Minimum investment
128% From funding target
Seed Medical Devices
• Overfunding - Over 200%
Accredited investors only
Lydus Medical

Lydus Medical

Lydus-Medical is revolutionizing the field of microsurgery, with an innovative medical device that automates the coupling of tiny blood vessels in complex procedures such as Breast reconstruction, Organ transplants, and Bypass surgery.

0

Units lefts

1

Days to go

$20,000

Minimum investment
250% From funding target
Seed + Medical Devices
• Overfunding - Over 100%
ElastiMed

ElastiMed

ElastiMed developed a wearable device designed to improve leg circulation, to treat venous and lymphatic diseases. The patented invention is expected to treat swelling, prevent DVT, reduce sports recovery time and improve the lives of millions worldwide.

14

Units lefts

15

Days to go

$10,000

Minimum investment
162% From funding target
Seed + Medical Devices
• Overfunding - Over 100%
Mobi

Mobi

Mobi is revolutionizing mobility for cities by equipping them with an AI-powered platform to understand mobility patterns, optimize traffic flow and reduce congestion by >30% across any road network.

18

Units lefts

29

Days to go

$10,000

Minimum investment
103% From funding target
Round A Transportation
• Overfunding - Over 100%
Aqueduct Medical

Aqueduct Medical

Aqdmedical has developed a cutting-edge, medical device that alleviates the complications of cervical dilation prior to intrauterine procedures. Following successful clinical trials, the company received FDA and CE approvals for its first product.

24

Units lefts

22

Days to go

$7,000

Minimum investment
100% From funding target
Seed Healthcare
Obvislim

Obvislim

OBVISLIM is developing ground-breaking technology that will allow customers to enjoy delicious food without regret, by reducing the absorption of sugars and fats. The company‘s products aim to revolutionize the enormous weight-loss and diabetes markets

24

Units lefts

11

Days to go

$7,000

Minimum investment
43% From funding target
Seed Healthcare

Our Story So Far

17,850‎

Investors in our community

$34,237,720

Raised to Date

72

Successfully funded campaigns

Be the first to hear about our new investment opportunities

Sign Up and we will keep you updated

Invest with Us

Our Startups

ExitValley connects you to a variety of attractive startups from Startup Nation

Our Investment Mechanism

ExitValley has developed an innovative investment mechanism that enables risks diversification, alongside secondary market feathers

Our Platform

ExitValley allows you to manage your investments efficiently, including ongoing investments monitoring while receiving all company reports

Raise Capital with Us

Our Numbers

ExitValley leads the field of equity crowdfunding in Israel with exceptional success rates and biggest rounds in Startup Nation

Our Investors Community

Gain access to ExitValley’s active and growing community of over 10,000 investors

Great Deal Terms

Our fundraising process is structured, fast and efficient, while our support team will provide you with a set of professional tools that will maximize your success rates

Partner with ExitValley

ExitValley recognizes the importance of a strong and rich network of partnerships for both start-ups and investors. With our growing success come many partnership opportunities


Need help?
The financing rounds made through the ExitValley platform are in accordance with a model of statutory exemption from publishing a prospectus pursuant to sections 15A(A)(1) and 15A(A)(7) to the Israeli companies law - 1965.
Under our model, the disclosure of detailed information on the company and information about the investment in each round of financing are limited to not more than 35 investors which are not qualified investors and the round of financing in not in the format of an offering arrangement ("רכז הצעה") as defined in the securities law
Follow us